Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity.

Chen RE, Smith BK, Errico JM, Gordon DN, Winkler ES, VanBlargan LA, Desai C, Handley SA, Dowd KA, Amaro-Carambot E, Cardosa MJ, Sariol CA, Kallas EG, S?kaly RP, Vasilakis N, Fremont DH, Whitehead SS, Pierson TC, Diamond MS. Implications of a highly divergent dengue virus strain for cross-neutralization, protection, and vaccine immunity. Cell Host Microbe. 2021 11 10; 29(11):1634-1648.e5.

View in: PubMed

subject areas

Animals
Antibodies, Viral
Antigens, Viral
Cross Protection
Cross Reactions
Dengue
Dengue Vaccines
Dengue Virus
Female
Genotype
Humans
Immunization, Passive
Macaca mulatta
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Viral Envelope Proteins

authors with profiles

Carlos A. Sariol, M.D.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support